905302-95-6

Upstream product

• 89-87-2 2,4-dimethylnitrobenzene 
• 4315-09-7 4-nitroisophthalic acid 
• 1374779-36-8 t-butyl 5-methoxycarbonyl-2-nitrobenzoate 
• 76143-33-4 5-(methoxycarbonyl)-2-nitrobenzoic acid 

Downstream Products

• 1374780-38-7 C₂₄H₃₀N₂O₃ 
• 1374779-39-1 C₂₁H₁₈ClNO₅S 
• 1374779-40-4 C₃₂H₃₁ClN₂O₅S 
• 1374777-67-9 2-(6-chlorobenzo[b]thiophene-2-carboxamido)-5-(4-phenoxypiperidine-1-carbonyl)benzoic acid 
• 905302-96-7 t-butyl 2-amino-5-carboxybenzoate 
• 1374779-37-9 C₂₄H₂₈N₂O₅ 

Relevant academic research and scientific papers

NEUROTRYPSIN INHIBITORS

The invention relates to acylamino-phthalic acid amides and related compounds of formula (I) wherein A is -CONR3R4,-NR5COR6, -NHR7, -OR8, -mR9, -CH2NRI0R11, -(CH2)2-R12, -CH=CH-R12, -C=C-R12, optionally substituted phenyl, optionally substituted thiophenyl, or optionally substituted 1,2,3-triazol-4-yl, W is hydrogen, hydroxy or carboxymethoxy, Y is carboxy, methoxycarbonyl or 2H-tetrazol-5-yl, and the various substituents R have the meanings indicated in the description. These compounds are useful for the treatment and/or prophylaxis of skeletal muscle atrophy, schizophrenia and Alzheimer?s disease, and as cognitive enhancers.